• Sativex

    Sativex® (manufactured by GW Pharmaceuticals, UK) is a cannabis-based pharmaceutical product containing delta 9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in a 1:1 ratio, delivered in an oromucosal (into the mouth) spray. Sativex has been approved in Canada as adjunctive treatment for neuropathic pain in adults with Multiple Sclerosis (MS) and in cancer pain. Registration is pending in several European countries. Sativex is on track to be approved by the FDA for USA sales sometime in 2018.

← Back to Glossary


Know what medicines work for you. OnlyYOU is the only way to test your unique genetic makeup to see how you respond to medicinal cannabis.
Order Now